CNF Antibodies

Santa Cruz Biotechnology features a diverse variety of CNF monoclonal antibodies for investigating C3 toxin's role in cellular processes. CNF monoclonal antibodies demonstrate effectiveness in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C3 toxin, produced by certain pathogenic bacteria, modifies Rho GTPases, leading to significant alterations in cell signaling and cytoskeletal dynamics. This modification results in various cellular responses, including changes in cell morphology, migration, and adhesion, making C3 toxin a critical factor in understanding bacterial pathogenesis and host interactions. CNF research plays a vital role in developing therapeutic strategies against bacterial infections. Understanding C3 toxin's mechanisms provides crucial information about bacterial virulence factors and their effects on host cells. Investigating CNF helps reveal complex cellular pathways involved in bacterial pathogenesis and immune responses. CNF monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance understanding of bacterial infections and develop innovative therapeutic approaches.